| ADsc | Unipolard | Bipolare | ||||
---|---|---|---|---|---|---|---|
Descriptor | Cases/total study group, n | HR (95% CI) | HR (95% CI)f | Cases/total study group, n | HR (95% CI)f | Cases/total study group, n | HR (95% CI)f |
DM without OAA | 42/1509 | Ref. | Ref. | 25/1509 | Ref. | 17/1509 | Ref. |
Metformin only | 43/1509 | 0.92 | 1.00 | 29/1509 | 1.28 | 14/1509 | 0.61 |
 |  | (0.59 to 1.45) | (0.61 to 1.64) |  | (0.68 to 2.40) |  | (0.22 to 1.65) |
DM without OAA | 140/2904 | Ref. | Ref. | 96/2904 | Ref. | 44/20904 | Ref. |
Sulfonylureas only | 145/2904 | 1.08 | 1.13 | 97/2904 | 1.14 | 48/2904 | 1.10 |
 |  | (0.84 to 1.38) | (0.87 to 1.47) |  | (0.83 to 1.56) |  | (0.68 to 1.78) |
DM without OAA | 282/5397 | Ref. | Ref. | 189/5397 | Ref. | 93/5397 | Ref. |
Sulfonylureas+ Metformin | 127/5397 | 0.40 | 0.42 | 83/5397 | 0.44 | 44/5397 | 0.38 |
 |  | (0.32 to 0.50)i | (0.33 to 0.53)i |  | (0.33 to 0.60)i |  | (0.25 to 0.58)i |
DM without OAA | 157/2843 | Ref. | Ref. | 109/2843 | Ref. | 48/2843 | Ref. |
SU+Met (SU first) | 60/2843 | 0.32 | 0.33 | 36/2843 | 0.32 | 24/2843 | 0.37 |
 |  | (0.23 to 0.44)i | (0.23 to 0.47)i |  | (0.21 to 0.50)i |  | (0.20 to 0.68)i |
DM without OAA | 33/968 | Ref. | Ref. | 18/968 | Ref. | 15/968 | Ref. |
SU+Met (Met first) | 19/968 | 0.53 | 0.45 | 10/968 | 0.45 | 9/968 | 0.50 |
 |  | (0.29 to 0.98)g | (0.23 to 0.89)g |  | (0.17 to 1.17) |  | (0.18 to 1.36) |
DM without OAA | 92/1586 | Ref. | Ref. | 62/1586 | Ref. | 30/1586 | Ref. |
SU+Met (the same time) | 48/1586 | 0.50 | 0.54 | 37/1586 | 0.65 | 11/1586 | 0.32 |
 |  | (0.35 to 0.72)i | (0.36 to 0.82)i |  | (0.40 to 1.04) |  | (0.14 to 0.75)h |